dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Medical technology

Sotsiaalministeerium · 6. august 2018
Viit
1.4-2/2615-1
Registreeritud
6. august 2018
Dokumendi liik
Sissetulev kiri
Adressaat
MedTech Europe
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2018
Vastutaja
Elen Ohov (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Eurokoordinatsiooni ja välissuhete osak.)

Failid

  • 📎E-kiri.pdf418 KB
  • 📎MTE_LettertoMoH_Estonia_August2018.pdf316 KB

Sisu (failidest)

Dear Minister Sikkut, Please find attached a letter from MedTech Europe - the European trade association representing the medical technology industry - for your urgent attention. We would appreciate your expeditious reply. Sincerely, Serge Bernasconi Chief Executive Officer Serge Bernasconi | Chief Executive Officer Dir. +32 2 777 02 71 | Mob. +32 479 66 59 39 http://www.medtecheurope.org/ htt https://www.facebook.com/MedTechEurope/ ps:/ htt htt /tw ps:/ ps:/ itte /w /w r.co ww ww m/ .lin .yo me ked utu dte in.c be. che om co uro /co m/ pe mp use any r/e /m uco edt me ech d -eu rop e http://www.medtechviews.eu/ Ms Riina Sikkut Minister of Health and Labour Suur-Ameerika 1, 10122 Tallinn, Republic of Estonia Prior via email Re.: Medical technology industry concerns about the readiness status of the new Medical Devices and In Vitro Diagnostic Regulations Brussels, 6 August 2018 Dear Minister Sikkut, We would like to alert you to a critical situation that may soon prevent your national healthcare system from being able to ensure continuity of care to patients. The reason is that the medical technology industry might not be able to (re-)certify many products due to the slow progress in building the infrastructure needed to transition into the new CE marking regulations. We therefore call for your urgent attention and action at the EU level to solve this alarming situation. To continue the supply of more than 500,000 currently available medical technologies to your hospitals, health care professionals and laboratories, manufacturers need to ensure compliance with the new EU Medical Devices Regulation (EU) 2017/745 (the ‘MDR’) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (the ‘IVDR’). These regulations entered into force on 26 May 2017 with a three and five-year transition time respectively. Since day one, our industry has invested heavily to comply to these new regulations. However, the manufacturers’ ability to place most products on the market is seriously jeopardized by the slow progress in putting the essential elements of the new regulatory systems in place. The most critical of these elements are the third-party conformity assessment bodies known as Notified Bodies. They are key for the new systems to operate. They must undergo a stringent (re-)designation process before they can assess and (re-)certify products under the rules of the new regulations. To be CE marked on time, nearly all medical technologies in your hospitals and laboratories depend on the early availability of these (re-)designated Notified Bodies. We understand that so far less than a half of today’s 59 Notified Bodies have applied for re-designation. For those that have applied, the process is far more complex and slower than anticipated. As of today, no Notified Body has been approved to certify medical technologies in Europe under the new regulations. MedTech Europe Rue Joseph II 40, 1000 Brussels – Belgium Tel. +32 2 300 96 43 – Fax. +32 2 300 96 44 [email protected] – www.medtecheurope.org It will take many months more before Notified Bodies are available to all the products and manufacturers who need them. By this time, the compliance deadlines of the regulations will either be imminent or have already passed. This all happens at the same time when all Notified Bodies are already experiencing chronic capacity challenges with the workload under the current directives. This will inevitably get worse in the coming months and years. We therefore urge you to enact appropriate solutions at EU level in a timely manner, i.e. before the 2019 EU elections, to allow the full operation of the new systems and the continuous supply of medical technology products beyond the dates of application of May 2020 and May 2022. Our industry is ready to engage in devising solutions that ensure adequate safety nets for the healthcare system and patients. We hope to have the opportunity to meet with you in the near future to further discuss this urgent topic in detail. Yours sincerely, Serge Bernasconi CEO, MedTech Europe About the Medical Technology Industry The medical technology industry provides more than 500,000 products to patients and healthcare system on a daily basis. Products comprise essential medical supplies like syringes and bandages, routine surgical equipment, patient monitoring devices as well as vast number of diagnostic tests, implants, imaging technology and digital solutions. Apart from medicines, nearly everything you see in a health institution is a medical technology product. MedTech Europe Rue Joseph II 40, 1000 Brussels – Belgium Tel. +32 2 300 96 43 – Fax. +32 2 300 96 44 [email protected] – www.medtecheurope.org
Allikas: Sotsiaalministeerium dokumendiregister →